Sökning: onr:"swepub:oai:lup.lub.lu.se:8c436475-3ff1-41c8-a073-6b257f4d5a86" > International Diabe...
Fältnamn | Indikatorer | Metadata |
---|---|---|
000 | 05903naa a2200529 4500 | |
001 | oai:lup.lub.lu.se:8c436475-3ff1-41c8-a073-6b257f4d5a86 | |
003 | SwePub | |
008 | 240402s2024 | |||||||||||000 ||eng| | |
024 | 7 | a https://lup.lub.lu.se/record/8c436475-3ff1-41c8-a073-6b257f4d5a862 URI |
024 | 7 | a https://doi.org/10.1016/j.diabres.2024.1115892 DOI |
040 | a (SwePub)lu | |
041 | a engb eng | |
042 | 9 SwePub | |
072 | 7 | a art2 swepub-publicationtype |
072 | 7 | a ref2 swepub-contenttype |
100 | 1 | a Bergman, Michaelu NYU Grossman School of Medicine4 aut |
245 | 1 0 | a International Diabetes Federation Position Statement on the 1-hour post-load plasma glucose for the diagnosis of intermediate hyperglycaemia and type 2 diabetes |
264 | 1 | c 2024 |
520 | a Many individuals with intermediate hyperglycaemia (IH), including impaired fasting glycaemia (IFG) and impaired glucose tolerance (IGT), as presently defined, will progress to type 2 diabetes (T2D). There is confirmatory evidence that T2D can be prevented by lifestyle modification and/or medications, in people with IGT diagnosed by 2-h plasma glucose (PG) during a 75-gram oral glucose tolerance test (OGTT). Over the last 40 years, a wealth of epidemiological data has confirmed the superior value of 1-h plasma glucose (PG) over fasting PG (FPG), glycated haemoglobin (HbA1c) and 2-h PG in populations of different ethnicity, sex and age in predicting diabetes and associated complications including death. Given the relentlessly rising prevalence of diabetes, a more sensitive, practical method is needed to detect people with IH and T2D for early prevention or treatment in the often lengthy trajectory to T2D and its complications. The International Diabetes Federation (IDF) Position Statement reviews findings that the 1-h post-load PG ≥ 155 mg/dL (8.6 mmol/L) in people with normal glucose tolerance (NGT) during an OGTT is highly predictive for detecting progression to T2D, micro- and macrovascular complications, obstructive sleep apnoea, cystic fibrosis-related diabetes mellitus, metabolic dysfunction-associated steatotic liver disease, and mortality in individuals with risk factors. The 1-h PG of 209 mg/dL (11.6 mmol/L) is also diagnostic of T2D. Importantly, the 1-h PG cut points for diagnosing IH and T2D can be detected earlier than the recommended 2-h PG thresholds. Taken together, the 1-h PG provides an opportunity to avoid misclassification of glycaemic status if FPG or HbA1c alone are used. The 1-h PG also allows early detection of high-risk people for intervention to prevent progression to T2D which will benefit the sizeable and growing population of individuals at increased risk of T2D. Using a 1-h OGTT, subsequent to screening with a non-laboratory diabetes risk tool, and intervening early will favourably impact the global diabetes epidemic. Health services should consider developing a policy for screening for IH based on local human and technical resources. People with a 1-h PG ≥ 155 mg/dL (8.6 mmol/L) are considered to have IH and should be prescribed lifestyle intervention and referred to a diabetes prevention program. People with a 1-h PG ≥ 209 mg/dL (11.6 mmol/L) are considered to have T2D and should have a repeat test to confirm the diagnosis of T2D and then referred for further evaluation and treatment. The substantive data presented in the Position Statement provides strong evidence for redefining current diagnostic criteria for IH and T2D by adding the 1-h PG. | |
650 | 7 | a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Endokrinologi och diabetes0 (SwePub)302052 hsv//swe |
650 | 7 | a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Endocrinology and Diabetes0 (SwePub)302052 hsv//eng |
700 | 1 | a Manco, Melaniau Bambino Gesù Children’s Hospital4 aut |
700 | 1 | a Satman, Ilhan4 aut |
700 | 1 | a Chan, Julianau Chinese University of Hong Kong4 aut |
700 | 1 | a Inês Schmidt, Mariau Hospital de Clinicas de Porto Alegre4 aut |
700 | 1 | a Sesti, Giorgiou Sapienza University of Rome4 aut |
700 | 1 | a Vanessa Fiorentino, Teresau University Magna Graecia4 aut |
700 | 1 | a Abdul-Ghani, Muhammadu University of Texas Health Science Centre4 aut |
700 | 1 | a Jagannathan, Ramu Emory University Rollins School of Public Health4 aut |
700 | 1 | a Kumar Thyparambil Aravindakshan, Pramodu Madras Diabetes Research Foundation4 aut |
700 | 1 | a Gabriel, Rafaelu Carlos III Health Institute4 aut |
700 | 1 | a Mohan, Viswanathanu Madras Diabetes Research Foundation4 aut |
700 | 1 | a Buysschaert, Martinu Saint-Luc University Hospital4 aut |
700 | 1 | a Bennakhi, Abdullah4 aut |
700 | 1 | a Pascal Kengne, Andreu South African Medical Research Council4 aut |
700 | 1 | a Dorcely, Brendau NYU Grossman School of Medicine4 aut |
700 | 1 | a Nilsson, Peter M.u Lund University,Lunds universitet,Internmedicin - epidemiologi,Forskargrupper vid Lunds universitet,Internal Medicine - Epidemiology,Lund University Research Groups,Skåne University Hospital4 aut0 (Swepub:lu)medf-pni |
700 | 1 | a Tuomi, Tiinamaijau Helsinki University Central Hospital,Folkhälsan Research Center4 aut0 (Swepub:lu)ti8736tu |
700 | 1 | a Battelino, Tadeju University of Ljubljana4 aut |
700 | 1 | a Hussain, Akhtaru Nord University,Federal University of Ceará4 aut |
700 | 1 | a Ceriello, Antoniou IRCCS Multimedica4 aut |
700 | 1 | a Tuomilehto, Jaakkou University of Helsinki,King Abdulaziz University,Finnish National Institute for Health and Welfare4 aut |
710 | 2 | a NYU Grossman School of Medicineb Bambino Gesù Children’s Hospital4 org |
773 | 0 | t Diabetes Research and Clinical Practiceg 209q 209x 0168-8227 |
856 | 4 | u http://dx.doi.org/10.1016/j.diabres.2024.111589y FULLTEXT |
856 | 4 8 | u https://lup.lub.lu.se/record/8c436475-3ff1-41c8-a073-6b257f4d5a86 |
856 | 4 8 | u https://doi.org/10.1016/j.diabres.2024.111589 |
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.
Kopiera och spara länken för att återkomma till aktuell vy